Director Michael Goettler resigns from Bausch Health board to become CEO of Knoa Pharma

Bausch Health Companies Inc.

Resignation effective June 30, 2026, due to appointment as President and CEO of Knoa Pharma LLC.
Mr. Goettler's departure was not due to any disagreement with the company.
Press release announcing the resignation was issued on July 1, 2026.
No other material changes to the board or management disclosed.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Goettler

Director

BHC · Bausch Health Companies Inc.

Effective: 2026-06-30
Filed: July 1, 2026, 4:23 PM ET

On June 26, 2026, Mr. Michael Goettler notified Bausch Health Companies Inc. (the “Company”) of his decision to resign from the Board of Directors (the “Board”), effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Goettler resigned as Director at Bausch Health Companies Inc..

Action: resigned
Role: Director

Exact text from the filing

On June 26, 2026, Mr. Michael Goettler notified Bausch Health Companies Inc. (the “Company”) of his decision to resign from the Board of Directors (the “Board”), effective June 30, 2026, in connection with his appointment as President and Chief Executive Officer of Knoa Pharma LLC.

View on SEC.gov

Bausch Health Companies Inc. filing history →

Source: SEC EDGAR

accession 0000885590-26-000089

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.